查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
肺癌治療市場 - 按類型（類癌、非小細胞和小細胞）、按療法[（放射、免疫療法（Durvalumab）、靶向（Bevacizumab）、化療]、按終端用戶（醫院、專科診所、家庭護理），全球預測，2023-2032年
市場調查報告書
商品編碼
1287292

肺癌治療市場 - 按類型（類癌、非小細胞和小細胞）、按療法[（放射、免疫療法（Durvalumab）、靶向（Bevacizumab）、化療]、按終端用戶（醫院、專科診所、家庭護理），全球預測，2023-2032年

Lung Cancer Treatment Market - By Type (Carcinoid, Non-small & Small Cell), By Therapy [(Radiation, Immunotherapy (Durvalumab), Targeted (Bevacizumab), Chemotherapy], By End-user (Hospitals, Specialty Clinics, Homecare), Global Forecast, 2023-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

全球肺癌治療市場規模將在2023-2032年間大幅成長。由於全球城市化進程加快和工業成長，空氣污染水平不斷上升，促使肺癌發病率增加，促進了對其治療的需求。根據世界衛生組織的預測，環境空氣污染將促使16%的肺癌死亡，而空氣污染可能促使全球約29%的肺癌死亡。疾病負擔的增加提高了人們對其早期診斷和治療的認識，以防止進一步的併發症，促進了市場的成長。

整個肺癌治療市場根據類型、療法、終端用戶和地區加以分類。

根據類型，類癌的市場佔有率將在2032年之前呈現顯著成長。越來越多的肺癌患病率和與之相關的高死亡率增加了對其治療的需求。根據美國癌症協會的數據，美國每年報告約有2000至4500個肺類癌腫瘤。此外，診斷技術的改進和對類癌認識的提高，推動了接受這種疾病治療的患者數量，從而增加了市場收入。

在治療方面，化療部分的肺癌治療市場價值將在2032年之前獲得巨大收益。基因組學和分子分析的進步使化療的個性化醫療成為可能。通過在分子水平上分析病人的腫瘤，醫生可以確定推動癌症生長的特定基因突變或生物標記。這些資訊有助於調整化療方案，以針對這些特定的異常情況，提高治療效果。

根據終端用戶，專科診所部分的肺癌治療市場將在2023-2032年觀察到可觀的成長。尖端診斷設備的高可用性使專科診所成為首選的醫療保健提供者。此外，這些設施處於有利地位，可以提供針對特定病人需求的個性化護理。它們提供全面的評估、分子剖析和臨床試驗的機會，確保病人得到最適當和有效的治療方案。

從區域來看，歐洲肺癌治療行業將在2023年至2032年期間以體面的複合年成長率成長。肺癌的高發病率增加了該地區對其治療的需求。此外，勃林格殷格翰國際有限公司、默克公司等行業競爭者的強大存在，不斷專注於開發先進的肺癌治療方案，對區域市場成長產生了積極影響。此外，該地區現有醫療基礎設施的快速擴張將刺激行業收入來源，直至2032年。

目錄

第一章：方法和範圍

第二章：執行摘要

第三章：肺癌治療行業洞察力

  • 行業生態系統分析
  • 行業影響力量
    • 成長動力
      • 全球範圍內肺癌的發病率不斷上升
      • 吸食煙草的趨勢不斷成長
      • 快速工業化促使的空氣污染水平的上升
      • 對癌症早期診斷的重視程度不斷提高
      • 肺癌治療的技術進步不斷提高
      • 肺癌治療可獲得報銷
    • 行業隱患與挑戰
      • 肺癌治療的高成本
      • 藥物和療法的副作用
  • 成長潛力分析
    • 按類型
    • 按療法分類
    • 按終端用戶分類
  • COVID-19影響分析
  • 臨床試驗分析
  • 監管情況
    • 美國
    • 歐洲
  • 技術格局
  • 波特的分析
  • PESTEL分析

第四章：競爭格局，2022年

  • 簡介
  • 2022年競爭態勢圖
  • 公司矩陣分析，2022年
  • 公司市場佔有率分析，2022年
  • 競爭定位矩陣，2022年
  • 戰略前景矩陣，2022年

第五章：肺癌治療市場估計和預測：按類型分類

  • 主要趨勢，按類型
  • 非小細胞肺癌
  • 小細胞肺癌
  • 類癌

第六章：肺癌治療市場估計和預測：按療法分類

  • 主要趨勢，按療法分類
  • 放射治療
  • 免疫療法
  • 靶向治療
  • 化療
  • 其他療法

第7章：肺癌治療市場估計和預測：按終端用戶分類

  • 主要趨勢，按終端用戶
  • 醫院
  • 專業診所
  • 家庭護理
  • 其他終端用戶

第八章：肺癌治療市場規模和預測：按地區分類

  • 主要趨勢，按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 亞太其他地區
  • 拉美地區
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • MEA
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第九章：公司簡介

  • Merck KGaA
  • ONO PHARMACEUTICAL CO., LTD.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline plc.
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited
  • Church & Dwight Co., Inc.
  • Sun Pharmaceutical Industries Ltd.Takara Bio Inc.
Product Code: 5708

Global Lung Cancer Treatment Market size will grow substantially during 2023-2032. Rising air pollution levels due to accelerating urbanization and industrial growth worldwide have resulted in increased incidences of lung cancer, bolstering the need for its treatment. As per the WHO, ambient air pollution is projected to lead to 16% of lung cancer deaths, while air pollution may be responsible for around 29% of the deaths caused by lung cancer globally. The increasing disease burden has bolstered awareness about its early diagnosis and treatment to prevent further complications, contributing to market growth.

The overall lung cancer treatment market is segmented based on type, therapy, end-user, and region.

Based on type, the market share from the carcinoid segment will depict significant growth through 2032. Growing prevalence of lung cancer and high mortality rate associated with it has increased the need for its treatment. According to the American Cancer Society, the U.S. reports around 2,000 to 4,500 lung carcinoid tumors every year. Moreover, improved diagnostic techniques and the rising awareness of carcinoid tumors have propelled the number of patients undergoing treatment of this condition, thus, adding to market revenue.

In terms of therapy, the lung cancer treatment market value from the chemotherapy segment will accrue significant gains through 2032. Advances in genomics and molecular profiling have enabled personalized medicine in chemotherapy. By analyzing a patient's tumor at a molecular level, doctors can identify specific genetic mutations or biomarkers that drive the cancer's growth. This information helps tailor the chemotherapy regimen to target those specific abnormalities, increasing treatment effectiveness.

Based on end-user, the lung cancer treatment market from the specialty clinics segment will observe appreciable growth over 2023-2032. High availability of cutting-edge diagnostic equipment has made specialty clinics a preferred healthcare provider. Additionally, these facilities are well-positioned to provide personalized care tailored to specific patient needs. They offer comprehensive evaluations, molecular profiling, and access to clinical trials, ensuring that patients receive the most appropriate and effective treatment options.

Regionally, Europe lung cancer treatment industry will grow at a decent CAGR from 2023 to 2032. High incidence rate of lung cancer has increased the need for its treatment in the region. Moreover, a strong presence of industry contenders such as Boehringer Ingelheim International GmbH, Merck KGaA, and others constantly focusing on developing advanced treatment options for lung cancer is positively impacting the regional market growth. Additionally, the rapid expansion of the existing healthcare infrastructure in the region will stimulate industry revenue streams through 2032.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Industry coverage
  • 1.2 Market definitions
  • 1.3 Base estimates and calculations
  • 1.4 Forecast calculations
  • 1.5 Data sources
  • 1.6 Data validation
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Lung Cancer Treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 By Therapy trends
    • 2.1.4 End-user trends
    • 2.1.5 Regional trends

Chapter 3 Lung Cancer Treatment Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of lung cancer across the globe
      • 3.2.1.2 The growing trend of smoking tobacco
      • 3.2.1.3 Rising levels of air pollution due to rapid industrialization
      • 3.2.1.4 Increasing emphasis on early diagnosis of cancers
      • 3.2.1.5 Rising technological advancements in lung cancer treatment
      • 3.2.1.6 Availability of reimbursement for lung cancer treatment
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 The high cost of lung cancer treatments
      • 3.2.2.2 Side effects of drugs and therapies
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By therapy
    • 3.3.3 By end-user
  • 3.4 COVID-19 impact analysis
  • 3.5 Clinical trial analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
  • 3.7 Technology landscape
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Competitive dashboard, 2022
  • 4.3 Company matrix analysis, 2022
  • 4.4 Company market share analysis, 2022
  • 4.5 Competitive positioning matrix, 2022
  • 4.6 Strategic outlook matrix, 2022

Chapter 5 Lung Cancer Treatment Market Estimates and Forecast, By Type (USD Million)

  • 5.1 Key trends, by type
  • 5.2 Non-small cell lung cancer
  • 5.3 Small cell lung cancer
  • 5.4 Carcinoid

Chapter 6 Lung Cancer Treatment Market Estimates and Forecast, By Therapy (USD Million)

  • 6.1 Key trends, by therapy
  • 6.2 Radiation therapy
  • 6.3 Immunotherapy
  • 6.4 Targeted therapy
  • 6.5 Chemotherapy
  • 6.6 Other therapies

Chapter 7 Lung Cancer Treatment Market Estimates and Forecast, By End-user (USD Million)

  • 7.1 Key trends, by end-user
  • 7.2 Hospitals
  • 7.3 Specialty clinics
  • 7.4 Homecare
  • 7.5 Other end-users

Chapter 8 Lung Cancer Treatment Market Size and Forecast, By Region (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 Merck KGaA
  • 9.2 ONO PHARMACEUTICAL CO., LTD.
  • 9.3 Boehringer Ingelheim International GmbH
  • 9.4 GlaxoSmithKline plc.
  • 9.5 Pfizer Inc.
  • 9.6 Johnson & Johnson Services, Inc.
  • 9.7 AstraZeneca
  • 9.8 Takeda Pharmaceutical Company Limited
  • 9.9 Church & Dwight Co., Inc.
  • 9.10 Sun Pharmaceutical Industries Ltd.Takara Bio Inc.

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market revenue, by type (2022)
  • TABLE 3. Market revenue, by therapy (2022)
  • TABLE 4. Market share, by end-user (2022)
  • TABLE 5. Market share, by region (2022)
  • TABLE 6. Global lung cancer treatment market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7. Global lung cancer treatment market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8. Global lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 9. Global lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 10. Global lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 11. Global lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 12. Global lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 13. Global lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 14. Industry impact forces
  • TABLE 15. Non-small cell lung cancer market size, 2018 - 2022 (USD Million)
  • TABLE 16. Non-small cell lung cancer market size, 2023 - 2032 (USD Million)
  • TABLE 17. Small cell lung cancer market size, 2018 - 2022 (USD Million)
  • TABLE 18. Small cell lung cancer market size, 2023 - 2032 (USD Million)
  • TABLE 19. Carcinoid size, 2018 - 2022 (USD Million)
  • TABLE 20. Carcinoid size, 2023 - 2032 (USD Million)
  • TABLE 21. Radiation therapy, market size, 2018 - 2022 (USD Million)
  • TABLE 22. Radiation therapy, market size, 2023 - 2032 (USD Million)
  • TABLE 23. External beam radiation therapy market size, 2018 - 2022 (USD Million)
  • TABLE 24. External beam radiation therapy market size, 2023 - 2032 (USD Million)
  • TABLE 25. Internal beam radiation therapy market size, 2018 - 2022 (USD Million)
  • TABLE 26. Internal beam radiation therapy market size, 2023 - 2032 (USD Million)
  • TABLE 27. Systemic radiation therapy market size, 2018 - 2022 (USD Million)
  • TABLE 28. Systemic radiation therapy market size, 2023 - 2032 (USD Million)
  • TABLE 29. Immunotherapy therapy market size, 2018 - 2022 (USD Million)
  • TABLE 30. Immunotherapy therapy market size, 2023 - 2032 (USD Million)
  • TABLE 31. Durvalumab market size, 2018 - 2022 (USD Million)
  • TABLE 32. Durvalumab market size, 2023 - 2032 (USD Million)
  • TABLE 33. Nivolumab market size, 2018 - 2022 (USD Million)
  • TABLE 34. Nivolumab market size, 2023 - 2032 (USD Million)
  • TABLE 35. Atezolizumab market size, 2018 - 2022 (USD Million)
  • TABLE 36. Atezolizumab market size, 2023 - 2032 (USD Million)
  • TABLE 37. Pembrolizumab market size, 2018 - 2022 (USD Million)
  • TABLE 38. Pembrolizumab market size, 2023 - 2032 (USD Million)
  • TABLE 39. Other immunotherapies market size, 2018 - 2022 (USD Million)
  • TABLE 40. Other immunotherapies market size, 2023 - 2032 (USD Million)
  • TABLE 41. Targeted therapy market size, 2018 - 2022 (USD Million)
  • TABLE 42. Targeted therapy market size, 2023 - 2032 (USD Million)
  • TABLE 43. Bevacizumab market size, 2018 - 2022 (USD Million)
  • TABLE 44. Bevacizumab market size, 2023 - 2032 (USD Million)
  • TABLE 45. Dabrafenib/Trametinib market size, 2018 - 2022 (USD Million)
  • TABLE 46. Dabrafenib/Trametinib market size, 2023 - 2032 (USD Million)
  • TABLE 47. Erlotinib hydrochloride market size, 2018 - 2022 (USD Million)
  • TABLE 48. Erlotinib hydrochloride market size, 2023 - 2032 (USD Million)
  • TABLE 49. Osimertinib market size, 2018 - 2022 (USD Million)
  • TABLE 50. Osimertinib market size, 2023 - 2032 (USD Million)
  • TABLE 51. Other targeted therapies market size, 2018 - 2022 (USD Million)
  • TABLE 52. Other targeted therapies market size, 2023 - 2032 (USD Million)
  • TABLE 53. Chemotherapy market size, 2018 - 2022 (USD Million)
  • TABLE 54. Chemotherapy market size, 2023 - 2032 (USD Million)
  • TABLE 55. Other therapies market size, 2018 - 2022 (USD Million)
  • TABLE 56. Other therapies market size, 2023 - 2032 (USD Million)
  • TABLE 57. Hospitals market size, 2018 - 2022 (USD Million)
  • TABLE 58. Hospitals market size, 2023 - 2032 (USD Million)
  • TABLE 59. Specialty clinics market size, 2018 - 2022 (USD Million)
  • TABLE 60. Specialty clinics market size, 2023 - 2032 (USD Million)
  • TABLE 61. Homecare market size, 2018 - 2022 (USD Million)
  • TABLE 62. Homecare market size, 2023 - 2032 (USD Million)
  • TABLE 63. Other end-users market size, 2018 - 2022 (USD Million)
  • TABLE 64. Other end-users market size, 2023 - 2032 (USD Million)
  • TABLE 65. North America lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 66. North America lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 67. North America lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 68. North America lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 69. North America lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 70. North America lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 71. North America lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 72. North America lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 73. North America lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 74. North America lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 75. North America lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 76. North America lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 77. North America lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 78. North America lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 79. U.S. lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 80. U.S. lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 81. U.S. lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 82. U.S. lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 83. U.S. lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 84. U.S. lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 85. U.S. lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 86. U.S. lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 87. U.S. lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 88. U.S. lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 89. U.S. lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 90. U.S. lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 91. Canada lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 92. Canada lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 93. Canada lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 94. Canada lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 95. Canada lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 96. Canada lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 97. Canada lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 98. Canada lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 99. Canada lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 100. Canada lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 101. Canada lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 102. Canada lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 103. Europe lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 104. Europe lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 105. Europe lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 106. Europe lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 107. Europe lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 108. Europe lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 109. Europe lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 110. Europe lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 111. Europe lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 112. Europe lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 113. Europe lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 114. Europe lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 115. Europe lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 116. Europe lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 117. Germany lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 118. Germany lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 119. Germany lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 120. Germany lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 121. Germany lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 122. Germany lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 123. Germany lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 124. Germany lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 125. Germany lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 126. Germany lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 127. Germany lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 128. Germany lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 129. UK lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 130. UK lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 131. UK lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 132. UK lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 133. UK lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 134. UK lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 135. UK lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 136. UK lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 137. UK lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 138. UK lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 139. UK lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 140. UK lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 141. France lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 142. France lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 143. France lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 144. France lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 145. France lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 146. France lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 147. France lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 148. France lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 149. France lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 150. France lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 151. France lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 152. France lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 153. Italy lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 154. Italy lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 155. Italy lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 156. Italy lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 157. Italy lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 158. Italy lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 159. Italy lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 160. Italy lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 161. Italy lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 162. Italy lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 163. Italy lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 164. Italy lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 165. Spain lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 166. Spain lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 167. Spain lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 168. Spain lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 169. Spain lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 170. Spain lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 171. Spain lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 172. Spain lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 173. Spain lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 174. Spain lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 175. Spain lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 176. Spain lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 177. Rest of Europe lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 178. Rest of Europe lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 179. Rest of Europe lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 180. Rest of Europe lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 181. Rest of Europe lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 182. Rest of Europe lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 183. Rest of Europe lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 184. Rest of Europe lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 185. Rest of Europe lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 186. Rest of Europe lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 187. Rest of Europe lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 188. Rest of Europe lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 189. Asia Pacific lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 190. Asia Pacific lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 191. Asia Pacific lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 192. Asia Pacific lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 193. Asia Pacific lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 194. Asia Pacific lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 195. Asia Pacific lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 196. Asia Pacific lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 197. Asia Pacific lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 198. Asia Pacific lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 199. Asia Pacific lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 200. Asia Pacific lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 201. Asia Pacific lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 202. Asia Pacific lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 203. China lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 204. China lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 205. China lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 206. China lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 207. China lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 208. China lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 209. China lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 210. China lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 211. China lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 212. China lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 213. China lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 214. China lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 215. Japan lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 216. Japan lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 217. Japan lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 218. Japan lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 219. Japan lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 220. Japan lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 221. Japan lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 222. Japan lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 223. Japan lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 224. Japan lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 225. Japan lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 226. Japan lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 227. India lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 228. India lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 229. India lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 230. India lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 231. India lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 232. India lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 233. India lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 234. India lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 235. India lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 236. India lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 237. India lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 238. India lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 239. Australia lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 240. Australia lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 241. Australia lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 242. Australia lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 243. Australia lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 244. Australia lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 245. Australia lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 246. Australia lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 247. Australia lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 248. Australia lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 249. Australia lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 250. Australia lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 251. Rest of Asia Pacific lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 252. Rest of Asia Pacific lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 253. Rest of Asia Pacific lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 254. Rest of Asia Pacific lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 255. Rest of Asia Pacific lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 256. Rest of Asia Pacific lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 257. Rest of Asia Pacific lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 258. Rest of Asia Pacific lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 259. Rest of Asia Pacific lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 260. Rest of Asia Pacific lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 261. Rest of Asia Pacific lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 262. Rest of Asia Pacific lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 263. Latin America lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 264. Latin America lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 265. Latin America lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 266. Latin America lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 267. Latin America lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 268. Latin America lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 269. Latin America lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 270. Latin America lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 271. Latin America lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 272. Latin America lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 273. Latin America lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 274. Latin America lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 275. Latin America lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 276. Latin America lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 277. Brazil lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 278. Brazil lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 279. Brazil lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 280. Brazil lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 281. Brazil lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 282. Brazil lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 283. Brazil lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 284. Brazil lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 285. Brazil lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 286. Brazil lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 287. Brazil lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 288. Brazil lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 289. Mexico lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 290. Mexico lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 291. Mexico lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 292. Mexico lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 293. Mexico lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 294. Mexico lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 295. Mexico lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 296. Mexico lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 297. Mexico lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 298. Mexico lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 299. Mexico lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 300. Mexico lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 301. Rest of Latin America lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 302. Rest of Latin America lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 303. Rest of Latin America lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 304. Rest of Latin America lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 305. Rest of Latin America lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 306. Rest of Latin America lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 307. Rest of Latin America lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 308. Rest of Latin America lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 309. Rest of Latin America lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 310. Rest of Latin America lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 311. Rest of Latin America lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 312. Rest of Latin America lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 313. Middle East & Africa lung cancer treatment market size, by country, 2018 - 2022 (USD Million)
  • TABLE 314. Middle East & Africa lung cancer treatment market size, by country, 2023 - 2032 (USD Million)
  • TABLE 315. Middle East & Africa lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 316. Middle East & Africa lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 317. Middle East & Africa lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 318. Middle East & Africa lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 319. Middle East & Africa lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 320. Middle East & Africa lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 321. Middle East & Africa lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 322. Middle East & Africa lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 323. Middle East & Africa lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 324. Middle East & Africa lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 325. Middle East & Africa lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 326. Middle East & Africa lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 327. South Africa lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 328. South Africa lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 329. South Africa lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 330. South Africa lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 331. South Africa lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 332. South Africa lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 333. South Africa lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 334. South Africa lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 335. South Africa lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 336. South Africa lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 337. South Africa lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 338. South Africa lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 339. Saudi Arabia lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 340. Saudi Arabia lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 341. Saudi Arabia lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 342. Saudi Arabia lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 343. Saudi Arabia lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 344. Saudi Arabia lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 345. Saudi Arabia lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 346. Saudi Arabia lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 347. Saudi Arabia lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 348. Saudi Arabia lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 349. Saudi Arabia lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 350. Saudi Arabia lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)
  • TABLE 351. Rest of Middle East & Africa lung cancer treatment market size, by type, 2018 - 2022 (USD Million)
  • TABLE 352. Rest of Middle East & Africa lung cancer treatment market size, by type, 2023 - 2032 (USD Million)
  • TABLE 353. Rest of Middle East & Africa lung cancer treatment market size, by therapy, 2018 - 2022 (USD Million)
  • TABLE 354. Rest of Middle East & Africa lung cancer treatment market size, by therapy, 2023 - 2032 (USD Million)
  • TABLE 355. Rest of Middle East & Africa lung cancer treatment market size, by radiation therapy, 2018 - 2022 (USD Million)
  • TABLE 356. Rest of Middle East & Africa lung cancer treatment market size, by radiation therapy, 2023 - 2032 (USD Million)
  • TABLE 357. Rest of Middle East & Africa lung cancer treatment market size, by immunotherapy, 2018 - 2022 (USD Million)
  • TABLE 358. Rest of Middle East & Africa lung cancer treatment market size, by immunotherapy, 2023 - 2032 (USD Million)
  • TABLE 359. Rest of Middle East & Africa lung cancer treatment market size, by targeted therapy, 2018 - 2022 (USD Million)
  • TABLE 360. Rest of Middle East & Africa lung cancer treatment market size, by targeted therapy, 2023 - 2032 (USD Million)
  • TABLE 361. Rest of Middle East & Africa lung cancer treatment market size, by end-user, 2018 - 2022 (USD Million)
  • TABLE 362. Rest of Middle East & Africa lung cancer treatment market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Lung Cancer Treatment industry 360 degree synopsis, 2018 - 2032
  • FIG. 8 Growth potential analysis, by type
  • FIG. 9 Growth potential analysis, by therapy
  • FIG. 10 Growth potential analysis, by end-user
  • FIG. 11 Porter's analysis
  • FIG. 12 PESTEL analysis
  • FIG. 13 Competitive dashboard, 2022
  • FIG. 14 Company matrix analysis, 2022
  • FIG. 15 Company market share analysis, 2022
  • FIG. 16 Competitive positioning matrix, 2022
  • FIG. 17 Strategic outlook matrix, 2022